You are here

Provenge

Dendreon ups its Provenge marketing game with help from NBA all-star Grant Hill

Fierce Pharma

Tue, 12/7/21 - 11:41 pm

pharma marketing

prostate cancer

celebrity endorsements

Bolt Biotherapeutics nabs $93.5M to push Provenge inventor's new idea deeper in the clinic

Endpoints

Wed, 07/1/20 - 11:19 am

Bolt Biotherapeutics

Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site

Fierce Pharma

Thu, 05/23/19 - 09:59 am

prostate cancer

drug manufacturing

ASCO: Dendreon touts T-cell response data for prostate cancer vaccine Provenge

Fierce Pharma

Tue, 06/6/17 - 09:55 am

prostate cancer

Dendreon eyes real-world data boost for lagging prostate cancer med Provenge

Fierce Pharma

Mon, 05/15/17 - 09:18 am

prostate cancer

5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them

Motley Fool

Sun, 11/20/16 - 05:37 pm

H.P. Acthar Gel

United Therapeutics

Valeant Pharmaceuticals

Gilead Sciences

9 Drugs That Cost Medicare a Fortune

Motley Fool

Sun, 04/10/16 - 01:29 pm

Can Valeant transform Dendreon's ailing Provenge into a viable cancer competitor?

Fierce Pharma Marketing

Wed, 02/11/15 - 12:04 pm

Valeant Pharmaceuticals

prostate cancer

Valeant Pharmaceuticals Signs Stalking-Horse Deal With Dendreon Corporation (DNDN)

Bidness Etc.

Fri, 01/30/15 - 08:19 am

Valeant Pharmaceuticals

Dendreon's Alternate Reality

Motley Fool

Thu, 12/4/14 - 10:40 am

prostate cancer

Dendreon's debt plans could leave stockholders in the lurch

Fierce Vaccines

Tue, 08/12/14 - 05:52 pm

Are Cancer Vaccines Worth an Investment?

Motley Fool

Thu, 07/10/14 - 10:28 am

Bristol-Myers Squibb

Dendreon's CEO Exits: Is this the Beginning of the End?

Motley Fool

Tue, 06/10/14 - 04:42 pm

Dendreon CEO Johnson Resigns as Provenge Overtaken by Rivals

Bloomberg

Mon, 06/9/14 - 07:43 pm

John H. Johnson

Why Dendreon (DNDN) Stock Is Surging Today

TheStreet.com

Tue, 05/20/14 - 11:22 am

prostate cancer

5 Biotechs With Prostate Cancer Treatments Worth Watching

Motley Fool

Sun, 04/6/14 - 10:21 am

prostate cancer

Seattle Genetics

Cancer Vaccines: Doomed to Fail?

Motley Fool

Mon, 03/24/14 - 10:01 am

cancer vaccines

Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros

Motley Fool

Tue, 03/4/14 - 12:31 pm

prostate cancer

Dendreon shares jump on news of prostate drug's European launch

Yahoo/Reuters

Mon, 03/3/14 - 10:03 am

prostate cancer

Galena Biopharma: The Oncologist's Perspective On A Life Saving Therapy

Seeking Alpha

Thu, 02/20/14 - 08:12 am

Galena Biopharma

prostate cancer

Pages